SEARCH

SEARCH BY CITATION

References

  • Andreano JM, Cahill L (2006). Glucocorticoid release and memory consolidation in men and women. Psychol Sci 17: 466470.
    Direct Link:
  • Barnes NM, Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38: 10831152.
  • Bright P, Jaldow E, Kopelman MD (2002). The national adult reading test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables. J Int Neuropsychol Soc 8: 847854.
  • Britt GC, McCance Katz EF (2005). A brief overview of the clinical pharmacology of ‘club drugs’. Subst Use Misuse 40: 11891201.
  • Brunner R, Schaefer D, Hess K, Parzer P, Resch F, Schwab S (2006). Effect of high-dose cortisol on memory functions. Ann N Y Acad Sci 1071: 434437.
  • Chiarotto JA, Wainer IW (1995). Determination of metyrapone and the enantiomers of its chiral metabolite metyrapol in human plasma and urine using coupled achiral-chiral liquid chromatography. J Chromatogr B Biomed Sci Appl 665: 147154.
  • Chiu SK, Collier CP (2003). Salivary cortisol on ROCHE Elecsys immunoassay system: pilot biological variation studies. Clin Biochem 36: 211214.
  • Cole JC, Sumnall HR (2003). Altered states: the clinical effects of Ecstasy. Pharmacol Ther 98: 3558.
  • Crawford JR, Deary IJ, Starr J, Whalley LJ (2001). The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval. Psychol Med 31: 451458.
  • Curran HV, Pooviboonsuk P, Dalton JA, Lader MH (1998). Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazapam and diphenhydramine. Psychopharmacology (Berl) 135: 2736.
  • Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J et al. (2009). Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab 94: 15481554.
  • Dumont GJ, Verkes RJ (2006). A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. J Psychopharmacol 20: 176187.
  • Erickson K, Drevets W, Schulkin J (2003). Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states. Neurosci Biobehav Rev 27: 233246.
  • Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M, Neri E et al. (2000). Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. Biol Psychiatry 47: 127136.
  • Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT (2002). Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 162: 396405.
  • Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT (2003). Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology 28: 16771684.
  • Kessels RP, Postma A, de Haan EH (1999). Object Relocation: a program for setting up, running, and analyzing experiments on memory for object locations. Behav Res Methods Instrum Comput 31: 423428.
  • Klaassen T, Riedel WJ, Deutz NE, Van Praag HM (2002). Mood congruent memory bias induced by tryptophan depletion. Psychol Med 32: 167172.
  • Kuypers KP, Ramaekers JG (2007a). Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacology (Berl) 189: 557563.
  • Kuypers KPC, Ramaekers JG (2005). Transient memory impairment after acute dose of 75 mg 3.4-Methylenedioxymethamphetamine. J Psychopharmacol 19: 633639.
  • Kuypers KPC, Ramaekers JG (2007b). Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacology (Berl) 189: 557563.
  • Lamers CTJ (2003). Influence of Marijuana and Ecstasy (MDMA) on Cognitive Function and Driving Performance. University of Maastricht: Maastricht.
  • Ljubijankic N, Popovic-Javoric R, Sceta S, Sapcanin A, Tahirovic I, Sofic E (2008). Daily fluctuation of cortisol in the saliva and serum of healthy persons. Bosn J Basic Med Sci 8: 110115.
  • McEwen BS (1998). Protective and damaging effects of stress mediators. N Engl J Med 338: 171179.
  • McEwen BS (2005). Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 54 (5 Suppl. 1): 2023.
  • Marin M-F, Hupbach A, Maheu FS, Nader K, Lupien SJ (2011). Metyrapone administration reduces the strength of an emotional memory trace in a long-lasting manner. J Clin Endocrinol Metab 96: 17.
  • Mas M, Farre M, de la Torre R, Roset PN, Ortuno J, Segura J et al. (1999). Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 290: 136145.
  • Mulder-Hajonides van der Meulen WREH, Wijnberg JR, Hollanders JJ, DeDiana I, Hoofdakker R (1980). Measurement of subjective sleep quality. Fifth European Congress on Sleep Research: Amsterdam.
  • Nejtek VA (2002). High and low emotion events influence emotional stress perceptions and are associated with salivary cortisol response changes in a consecutive stress paradigm. Psychoneuroendocrinology 27: 337352.
  • Parrott AC (2001). Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 16: 557577.
  • Parrott AC (2009). Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users. Neuropsychobiology 60: 148158.
  • Parrott AC, Lock J, Conner AC, Kissling C, Thome J (2008). Dance clubbing on MDMA and during abstinence from ecstasy/MDMA: prospective neuroendocrine and psychobiological changes. Neuropsychobiology 57: 165180.
  • Parrott AC, Gibbs A, Scholey AB, King R, Owens K, Swann P et al. (2011). MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. Psychopharmacology (Berl) 215: 527536.
  • Pizarro N, Ortuño J, Farré M, Hernández-López C, Pujadas M, Llebaria A et al. (2002). Determination of MDMAand its metabolitesin blood and urine by gas chromatography-mass spectrometry and analysis of enantiomersby capillary electrophoresis. J Anal Toxicol 26: 157165.
  • Price LH, Ricaurte GA, Krystal JH, Heninger GR (1989). Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations. Arch Gen Psychiatry 46: 2022.
  • Ramaekers JG, Kuypers KPC, Wingen M, Heinecke A, Formisano E (2009). Involvement of inferior parietal lobules in prospective memory impairment during acute MDMA (Ecstasy) intoxication: an event-related fMRI study. Neuropsychopharmacology 34: 16411648.
  • Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW et al. (2001). Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92: 179212.
  • Rey A (1958). The Clinical Examination in Psychology/L'examen Clinique En Psychologie. Presses Universitaires De France: Oxford.
  • Riedel WJ, Sobczak S, Nicolson N, Honig A (2002). Stress, cortisol and memory as markers of serotonergic vulnerability. Acta Neuropsychiatrica 14: 186191.
  • Sawin CT, Spark RF, Mitchell ML (1971). Lack of response of serum growth hormone to metyrapone. J Clin Endocrinol Metab 32: 854856.
  • Schmand B, Bakker D, Saan R, Louman J (1991). De Nederlandse Leestest voor Volwassenen: een maat voor het premorbide intelligentieniveau. Tijdschr Gerontol Geriatr 22: 1519.
  • Scholey AB, Owen L, Gates J, Rodgers J, Buchanan T, Ling J et al. (2011). Hair MDMA samples are consistent with reported ecstasy use: findings from a study investigating the effects of ecstasy on mood and memory. Neuropsychobiology 63: 1521.
  • Sternberg S (1966). High-speed scanning in human memory. Science 153: 652654.
  • Suda M, Morimoto K, Obata A, Koizumi H, Maki A (2008). Emotional responses to music: towards scientific perspectives on music therapy. Neuroreport 19: 7578.
  • Van Honk J, Kessels RPC, Putman P, Jager G, Koppeschaar HPF, Postma A (2003). Attentionally modulated effects of cortisol and mood on memory for emotional faces in healthy young males. Psychoneuroendocrinology 28: 941948.
  • Van Strien JW, Verkoeijen PP, Van der Meer N, Franken IH (2007). Electrophysiological correlates of word repetition spacing: ERP and induced band power old/new effects with massed and spaced repetitions. Int J Psychophysiol 66: 205214.
  • Verkes RJ, Gijsman HJ, Pieters MS, Schoemaker RC, de Visser S, Kuijpers M et al. (2001). Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology (Berl) 153: 196202.
  • van Wel JHP, Kuypers KPC, Theunissen EL, Bosker WM, Bakker K, Ramaekers JG (2011). Blockade of 5-HT2 receptor selectively prevents MDMA induced verbal memory impairment. Neuropsychopharmacology 36: 19321939.
  • van Wel JHP, Kuypers KPC, Theunissen EL, Bosker WM, Bakker K, Ramaekers JG (2012). Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors. PLoS ONE 7: e40187.
  • White SR, Obradovic T, Imel KM, Wheaton MJ (1996). The effects of methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol 49: 455479.
  • Wingen M, Kuypers KPC, Ramaekers JG (2007). Selective verbal and spatial memory impairment after 5-HT1a and 5-HT2a receptor blockade in healthy volunteers pre-treated with an SSRI. J Psychopharmacol 21: 477485.
  • Winhusen T, Somoza E, Harrer JM, Moore E, Ussery T, Kropp F et al. (2005). Metyrapone and cocaine: a double-blind, placebo-controlled drug interaction study. Pharmacol Biochem Behav 80: 631638.
  • de Wit H, Enggasser JL, Richards JB (2002). Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27: 813825.
  • Young EA, Ribeiro SC (2006). Sex differences in the ACTH response to 24H metyrapone in depression. Brain Res 1126: 148155.